Reduce Risk of Hospital-Acquired Infections

Reducing the risk of Hospital-Acquired Infections (HAIs) is essential in operating rooms, where surgical site infections (SSIs) pose significant risks to patients. SSIs can cause complications, prolong hospital stays, and increase costs.

UV222 technology uses a specific Far-UVC wavelength at 222 nm to effectively destroy bacteria, viruses, and fungi, without harming human tissues when applied within regulatory limits. By integrating UV222 into operating rooms,  microbial levels on surfaces and in the air are significantly reduced, lowering the risk of SSIs.

This advancement offers a continuous, automated alternative to traditional methods, aligning with the healthcare industry’s push towards innovative patient safety measures. UV222 technology is transforming the fight against SSIs and other HAIs.